Research

Current Research

The cornerstone of Parent Project Muscular Dystrophy’s mission is to identify and support promising Duchenne muscular dystrophy research that can impact all those living with Duchenne now, during their lifetime. No one in this community will deny the importance of a robust research program, and since our founding in 1994, PPMD has supported innovation we believe has the possibility to treat every single person living with Duchenne.

In this section you will find basic information about various Research Strategies for potential treatments, the Therapeutic Approaches, and specific drugs in the Drug Development Pipeline now.

Explore

Our Strategy & impact

Since 1994, PPMD has invested in every single therapeutic possibility for Duchenne. We take a cutting-edge approach to accelerate finding treatments that will end Duchenne for every single person impacted by the disease.

Therapeutic Approaches

It is thought that not any one treatment will end Duchenne, but rather successfully treating Duchenne will require a multi-faceted approach. This is why PPMD supports the idea of combination therapies.

Drug Development Pipeline

The Drug Development Pipeline is full of potential treatments that are being tested. Click on any drug in our interactive pipeline to learn more about therapies in development for Duchenne.

Research

Current Research